Kangmin WANG,Hong ZHAO,Guizhen LU,Chun WU,Lifen ZHANG,Chenghuan YANG,Jingjing WANG
申请号：
US16720108
公开号：
US20200121751A1
申请日:
2019.12.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to medicines, and more particularly to an abortion medication and an administration thereof, where the abortion medication contains 40-60 mg/mL of a kidney bean lectin. The invention also provides another abortion medication, which contains 40-60 mg/mL of a kidney bean lectin, 40-50 mg/mL of an oligosaccharide and 6-9 mg/mL of NaCl. The two abortion medications provided herein are both capable of effectively terminating the pregnancy and are safe without toxic side effects. Moreover, these drugs can be reused several times. These abortion medications are administered intrauterinely, which enables the kidney bean lectin therein to show the best abortive effect, and the local administration of these drugs in the uterine cavity has relatively simple operation.
